Document Classification

Section Type: RESULTS

Text: There were differences in the VAS in favour of the alginate at 2 weeks (29 + / - 22 vs. 35 + / - 25, P = 0. 01) at 4 weeks (13 + / - 17 vs. 20 + / - 23, P = 0. 001), for the number of episodes at 4 weeks (2 + / - 2 vs. 3 + / - 4, P = 0. 001), for pain interfering with daily activities (3 % vs. 10 %, P = 0. 009), for pain disturbing sleep (2 % vs. 9 %, P = 0. 004), and for the proportion of patients considered as treatment failures (11 % vs. 24 %, P < 0. 001).